Integra prices $450 million notes due 2033
Integra Lifesciences priced $450 million of 9.500% senior secured notes due 2033 as part of a debt refinancing.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Integra Lifesciences priced $450 million of 9.500% senior secured notes due 2033 as part of a debt refinancing.
Integra LifeSciences priced $450 million of 9.500% senior secured notes due 2033. The company said it expects to use the proceeds, with new credit facilities, to refinance existing credit facilities and cover related fees and expenses.